EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project

Sara Faghihi-Kashani iD, Akira Yoshida iD, Francisca Bozan iD, Giovanni Zanframundo iD, Davide Rozza iD, Aravinthan Loganathan iD, Eduardo Dourado iD, Gianluca Sambataro iD, Iazsmin Bauer-Ventura iD, Sangmee Sharon Bae iD, Darosa Lim iD, Daphne Rivero-Gallegos iD und 44 weitere

Arthritis & Rheumatology · 2025-04 · 77 (4) · 477-489

DOI: 10.1002/art.43038 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Arthritis & Rheumatology, online erschienen am 17.12.2024. Verfasst von Sara Faghihi-Kashani und 55 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Myositis, Autoimmune Diseases. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: American College of Rheumatology Research and Education Foundation, Intramural NIH HHS, European League Against Rheumatism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Anti‐synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data‐driven classification criteria for ASSD.

Methods

We used a large, international, multicenter “Classification Criteria for Anti‐synthetase Syndrome” (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort.

Results

Our analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo‐1 and non–Jo‐1 anti‐synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti‐Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD.

Conclusion

We identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data‐driven classification criteria for ASSD. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyositisAutoimmune DiseasesHumansMaleFemaleMiddle AgedAdultLung Diseases, InterstitialAgedAutoantibodiesAntibodies, AntinuclearMuscle WeaknessHypertension, PulmonaryCase-Control StudiesArthritis

Substanzen

AutoantibodiesAntibodies, Antinuclear

Autor:innen und Institutionen

  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
  • Hospital Clínico Universidad de Chile, Santiago, Chile.
  • Università di Pavia and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
  • Italian Society of Rheumatology, Milan, Italy.
  • Royal National Hospital for Rheumatic Diseases and University of Bath, Bath, UK, and Arthritis Australia, Broadway, Glebe, New South Wales, Australia.

ORCID-Profile: Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza, Aravinthan Loganathan, Eduardo Dourado, Gianluca Sambataro, Iazsmin Bauer-Ventura, Sangmee Sharon Bae, Darosa Lim, Daphne Rivero-Gallegos, Yasuhiko Yamano, Albert Selva-O'Callaghan, Andrew L Mammen, Carlo A Scirè, Carlomaurizio Montecucco, Chester V Oddis, David Fiorentino, Francesco Bonella, Frederick W Miller, Ingrid E Lundberg, Jens Schmidt, Jorge Rojas-Serrano, Marie Hudson, Masataka Kuwana, Miguel Angel González-Gay, Neil McHugh, Tamera J Corte, Tracy Jennifer Doyle, Victoria P Werth, Latika Gupta, Diana Isabel Perez Roman, Phani Kumar Devarasetti, Samuel Katsuyuki Shinjo, Fabrizio Luppi, Ilaria Cavazzana, Siamak Moghadam-Kia, Marco Fornaro, Elizabeth R Volkmann, Matteo Piga, Jesus Loarce-Martos, Giacomo De Luca, Johannes Knitza, Veronica Wolff-Cecchi, Marco Sebastiani, Adam Schiffenbauer, Lisa G Rider, Raquel Campanilho-Marques, Lucian Marts, Elena Bravi, Harsha Gunawardena, Rohit Aggarwal, Lorenzo Cavagna

Förderung

  • American College of Rheumatology Research and Education Foundation
  • Intramural NIH HHS
  • European League Against Rheumatism
  • NIEHS NIH HHS
  • NIAMS NIH HHS
  • National Institute of Environmental Health Sciences

Zitieren

APA

Faghihi-Kashani, S., Yoshida, A., Bozan, F., Zanframundo, G., Rozza, D., Loganathan, A., Dourado, E., Sambataro, G., Bauer-Ventura, I., Bae, S. S., Lim, D., Rivero-Gallegos, D., Yamano, Y., Selva-O'Callaghan, A., Mammen, A. L., Scirè, C. A., Montecucco, C., Oddis, C. V., Fiorentino, D., …, & Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators (2025). Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project. Arthritis & Rheumatology, 77(4), 477-489. https://doi.org/10.1002/art.43038

Vancouver

Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, et al. Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project. Arthritis & Rheumatology. 2025;77(4):477-489. doi:10.1002/art.43038

BibTeX
@article{FaghihiKashani2025,
  author = {Faghihi-Kashani, Sara and Yoshida, Akira and Bozan, Francisca and Zanframundo, Giovanni and Rozza, Davide and Loganathan, Aravinthan and Dourado, Eduardo and Sambataro, Gianluca and Bauer-Ventura, Iazsmin and Bae, Sangmee Sharon and Lim, Darosa and Rivero-Gallegos, Daphne and Yamano, Yasuhiko and Selva-O'Callaghan, Albert and Mammen, Andrew L and Scirè, Carlo A and Montecucco, Carlomaurizio and Oddis, Chester V and Fiorentino, David and Bonella, Francesco and Miller, Frederick W and Lundberg, Ingrid E and Schmidt, Jens and Rojas-Serrano, Jorge and Hudson, Marie and Kuwana, Masataka and González-Gay, Miguel Angel and McHugh, Neil and Corte, Tamera J and Doyle, Tracy Jennifer and Werth, Victoria P and Gupta, Latika and Perez Roman, Diana Isabel and Bianchessi, Lorenzo M and Devarasetti, Phani Kumar and Shinjo, Samuel Katsuyuki and Luppi, Fabrizio and Cavazzana, Ilaria and Moghadam-Kia, Siamak and Fornaro, Marco and Volkmann, Elizabeth R and Piga, Matteo and Loarce-Martos, Jesus and De Luca, Giacomo and Knitza, Johannes and Wolff-Cecchi, Veronica and Sebastiani, Marco and Schiffenbauer, Adam and Rider, Lisa G and Campanilho-Marques, Raquel and Marts, Lucian and Bravi, Elena and Gunawardena, Harsha and Aggarwal, Rohit and Cavagna, Lorenzo and Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators, Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators},
  title = {Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {4},
  pages = {477--489},
  doi = {10.1002/art.43038}
}
Kostenlos starten →